Dr. Robert Weinstock, Director of Cataract and Refractive Surgery at The Eye Institute of West Florida, became the first surgeon in the USA to implant Rayner’s RayOne IOL.
FDA-approved cataract lens, RayOne EMV, was developed to provide clear, crisp vision at distance and intermediate ranges of vision.
Dr. Mariano Royo, Director of Ophthalmology at the Hospital San Rafael in Madrid and Director of the Ophthalmic Institute of Madrid, shared his clinical results of 22 eyes of 11 patients implanted with RayOne EMV measured at 6 months post-op. Dr. Royo reported that 100% of his patients that received RayOne EMV achieved spectacle independence in the distance and intermediate range. The average reading aid at 33 cm was reported to be +1.5 D, and one in three patients had functional near vision without the need for spectacles.1
RayOne EMV is a cost-effective solution for patients when other IOLs may be cost prohibitive.
“Following approval of our RayOne and RayPRO platforms in 2019 we have been steadily increasing our investment in the USA to be one of our most important markets worldwide,” Tim Clover, Rayner CEO, said in a company news release. “The approval of RayOne EMV is important as it allows surgeons to offer patients a new option which has been tried and tested in thousands of patients around the world”
Being at the forefront of innovative technology has allowed our The Eye Institute of West Florida to deliver above average visual outcomes to patients undergoing cataract surgery. With many IOLs (intra-ocular lenses) to choose from, The Eye Institute of West Florida ensures you will meet your visual goals based on your particular lifestyle needs.
Click here or call (727) 581-8706 set up a cataract consultation with one of our specialists.
1 Royo, M. RayOne EMV and TECNIS Eyhance: A Comparative Clinical Defocus Curve. Data on file. 2021.
Meet Your Cataract Specialist
Robert J. Weinstock, M.D. is a board-certified ophthalmologist and is fellowship-trained in cataract and refractive surgery. He became interested in ophthalmology at an early age – as he watched and assisted his father. Dr. Weinstock has joined the practice in 2001 after completing his residency at the St. Louis University School of Medicine.
He is the Director of Cataract and Refractive Services at the Eye Institute of West Florida and The Weinstock Laser Eye Center. He also is an associate clinical professor of ophthalmology at the University of South Florida and serves as the Surgical Director of the Largo Ambulatory Surgery Center. He was named one of 250 in Premier Surgeon’s List of Leading Innovators of 2010 for his contributions to cataract surgery and premium IOLs. In addition to performing thousands of vision correcting cataract and LASIK procedures each year, Dr. Weinstock speaks and teaches nationally and internationally on customized cataract surgery and surgical innovations. He is continuously engaged in clinical research and studies to evaluate new technology, many of which are sanctioned by the FDA. He is recognized internationally as an expert on new implant technology and micro incisional surgical techniques. He has authored many book chapters on cataract surgery and continues to write journal articles on cataract and refractive surgery.